Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement

Oliver Pfaar; Ludger Klimek; Marek Jutel; Cezmi Akdis; Jean Bousquet; Mübeccel Akdis; Claus Bachert; Ioana Agache; Ignacio Ansotegui; Anna Bedbrook; Sinthia Bosnic-Anticevich; Giorgio W. Canonica; Tomas Chivato; Alvaro A. Cruz; Wienia Czarlewski; Stefano Del Giacco; Hui Du; Joao A. Fonseca; Yadong Gao; Tari Haahtela; Karin Hoffmann-Sommergruber; Juan Carlos Ivancevich; Nikolai Khaltaev; Edward F. Knol; Piotr Kuna; Desiree Larenas-Linnemann; Erik Melen; Joaquim Mullol; Robert Naclerio; Ken Ohta; Yoshitaka Okamoto; Liam O’Mahony; Gabrielle L. Onorato; Nikos G. Papadopoulos; Ruby Pawankar; Boleslaw Samolinski; Jurgen Schwarze; Sanna Toppila-Salmi; Mohamed H. Shamji; Maria Teresa Ventura; Arunas Valiulis; Arzu Yorgancioglu; Paolo Matricardi; Torsten Zuberbier

Journal ArticleOPEN ACCESS

Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement

Allergy: European Journal of Allergy and Clinical Immunology (2020) 75(7) 1546-1554

DOI: 10.1111/all.14336

100Citations

238Readers

Author supplied keywords

Cite

CITATION STYLE

APA

Pfaar, O., Klimek, L., Jutel, M., Akdis, C., Bousquet, J., Akdis, M., … Zuberbier, T. (2020). Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement. Allergy: European Journal of Allergy and Clinical Immunology, 75(7), 1546–1554. https://doi.org/10.1111/all.14336

Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement

Author supplied keywords

Cite

Register to see more suggestions